When the University of Utah officials unexpectedly fired Mary Beckerle from her job as CEO and director of the Huntsman Cancer Institute earlier this week, they made an enemy few people in the state would wish for: the powerful Huntsman family.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
